India proposes uniform code for pharma marketing; compliance may become mandatory
This article was originally published in SRA
The Indian government has proposed a first-ever uniform voluntary code of conduct on marketing practices for the pharmaceutical industry1,2. Compliance with the code may become mandatory if, after six months of coming into effect, the government finds that the code has not been implemented effectively by drug companies/industry associations.
You may also be interested in...
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
The Canadian medtech regulator has recommended updating its list of recognized medical device standards that manufacturers can rely on to demonstrate compliance with local safety, effectiveness and labeling requirements.
Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. While the European Medicines Agency has launched an investigation, Australia is examining the need for specific warnings about risks of vaccination in the very frail elderly or terminally ill patients.